Cancer Diagnosis in Patients with Heart Failure: Epidemiology, Clinical Implications and Gaps in KnowledgePietro Ameri, Carlo G. Tocchetti, Mitja Lainščak et al.|European Journal of Heart Failure|2018Cited by 183
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term RegistryMarco Canepa, Marème Konté, Cândida Fonseca et al.|JACC Heart Failure|2018Cited by 156
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Francesco Cappelli et al.|Journal of the American College of Cardiology|2024Cited by 137
Characteristics, Treatments and 1-Year Prognosis of Hospitalized and Ambulatory Heart Failure Patients with Chronic Obstructive Pulmonary Disease in the European Society of Cardiology Heart Failure Long-Term RegistryMarco Canepa, Luigi Tavazzi, Ewa Straburzyńska‐Migaj et al.|European Journal of Heart Failure|2017Cited by 114
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the <scp>AC‐TIVE</scp> study, an <scp>Italian nationwide survey</scp>Marco Merlo, Gianfranco Sinagra, Linda Pagura et al.|European Journal of Heart Failure|2022Cited by 91